PrecisionLife

🚀 PrecisionLife wins €2.5m EIC grant to transform endometriosis triage & treatment with unique precision medicine insights 🎉 We’re thrilled to announce that #ProjectTRANSCEND has been awarded a multi-million grant from the European Innovation Council (EIC)! Endometriosis is a complex and debilitating disease affecting 190 million women worldwide, yet diagnosis takes an average of 8–10 years through invasive laparoscopic surgery. This must change. TRANSCEND will develop and clinically validate a rapid, non-invasive precision medicine test using a simple buccal swab. This test will: ✅ Evaluate an individual’s lifetime risk of endometriosis ✅ Uncover disease mechanisms to guide personalized treatments ✅ Enable faster, more accurate triage and specialist referrals ✅ Accelerate repurposed drug trials for better treatment options Our mission is clear: ✔️ Triage & refer faster ✔️ Treat more effectively ✔️ Improve millions of lives Huge thanks to the European Innovation Council and SMEs Executive Agency (EISMEA) for recognizing the urgency of addressing this global health challenge. With this support, we’re working to close the diagnostic gap, improve patient health outcomes, and reduce the cost of care. 🔗 Read more: https://lnkd.in/ez3KHhhA #EndometriosisAwareness #PrecisionMedicine #WomensHealth #EICAccelerator #EUeic #ProjectTRANSCEND

We're delighted to announce that Simon Beaulah, our SVP Healthcare & Head of US Operations, will be presenting in the AI for Drug Discovery & Development track at 𝗕𝗶𝗼-𝗜𝗧 𝗪𝗼𝗿𝗹𝗱 2025 in Boston, MA. 📅 𝗘𝘃𝗲𝗻𝘁 𝗱𝗮𝘁𝗲: April 16-18, 2025 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Boston, MA 🗣️ 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻: Increasing Probability of R&D Success from Concept to Clinic with Causal AI & Mechanostics Simon will share how PrecisionLife’s powerful combinatorial analytics platform is driving novel insights into the complex biology of chronic diseases. By analyzing rich multiomic data with advanced AI-driven combinatorial analytics, we’re uncovering novel disease mechanisms, biomarkers, and treatment opportunities to support new precision medicine strategies. If you're attending Bio-IT World, don’t miss this opportunity to hear groundbreaking insights and discover how we're accelerating the development of better, more personalized diagnostic tools and treatments for patients worldwide with complex, chronic diseases. 🔗 Learn more about our participation at Bio-IT World here: https://lnkd.in/eUe4RS-6 #PrecisionMedicine #BioITWorld2025

New insights are unlocking vital breakthroughs in understanding the genetic factors behind #LongCOVID and associated complex conditions such as #MECFS, offering hope for improved #diagnostics and targeted #treatments. In her recent article for Tech.eu, Cate Lawrence highlights the potential impact of PrecisionLife research on improving #healthspan and addressing the long-term effects of #COVID. We're proud to be at the forefront of this work, using our AI-driven combinatorial analytics platform to identify risk-associated genes and pave the way for more effective precision medicine approaches. Special thanks also to Hevolution Foundation for facilitating Cate's discussion with Steve Gardner at the excellent Global Healthspan Summit and for sharing our commitment to improving healthcare outcomes and extending healthspan for billions of people. Read more about these groundbreaking discoveries here: https://lnkd.in/exq2HbXq #AIinHealthcare #PrecisionMedicine #Genomics #LongCOVIDResearch

PrecisionLife will participate in a panel discussion at the 32nd Annual Precision Med Tri-Con in San Diego. 𝗣𝗮𝗻𝗲𝗹 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: Omics, Data, and AI in Precision Medicine 𝗗𝗮𝘁𝗲 & 𝗧𝗶𝗺𝗲: 12:00 PM PST, Wednesday, March 12, 2025 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: San Diego, CA Our CEO, Steve Gardner, will join expert panelists to explore the integration of omics data and AI in advancing precision medicine: • Kyle Farh, MD, PhD – Vice President & Distinguished Scientist, Artificial Intelligence Lab, Illumina • Ryan Taft, PhD – Senior Vice President, Genomics R&D, Tempus AI • Eleanor Howe, PhD – Founder & CEO, Diamond Age Data Science The discussion will be moderated by Fay Lin, PhD, Senior Editor at Genetic Engineering & Biotechnology News. The panel will delve into key considerations for omics data generation and curation, addressing challenges like data accessibility and representation that are critical to realizing AI's full potential in precision medicine. We invite attendees to connect with us during the conference to explore collaborative opportunities aimed at improving health outcomes through world-leading precision medicine insights. #PrecisionMedicine #OmicsData #PrecisionMedTriCon2025

Our afternoon sessions at the #AIinDrugDiscovery Conference included updates from the likes of Insilico Medicine, PrecisionLife, Recursion and CHARM Therapeutics: 🧬 Petrina Kamya, Ph.D., President of Insilico Medicine Canada Inc., and Global Head of AI Platforms, VP at Insilico Medicine, provided an update from Insilico Medicine’s lead candidate, #Rentosertib, which was today given its official generic name. Alongside this, Petrina dived into the specifics of the AI platform Insilico Medicine are using to discover and develop this promising drug candidate, alongside a robust pipeline! 🧬 Karen Sayal, Senior Director at Recursion explained how Recursion are harnessing LLM-based AI agents to create complex clinical workflows and aid in patient interaction. 🧬 From Hannah Bruce Macdonald, Associate Principal Scientist at CHARM Therapeutics we learned how physics-based modelling and additional proprietary data can supplement Charm’s #Dragonfold platform for AI-driven prediction of protein-ligand co-folding. 🧬 And last but not least, a resounding presentation from Krystyna Taylor, VP of Portfolio Strategy at PrecisionLife, on how genetic patient stratification can drive faster patient diagnosis and discovery of novel precision medicines, for previously hard to treat diseases. #AIDrugDis #AIDrugDis25

Our CEO, Steve Gardner, will be presenting at the 32nd Annual Precision Med Tri-Con in San Diego. 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀: • 𝗧𝗶𝘁𝗹𝗲: Improving the Prediction, Treatment, & Prevention of Chronic Diseases • 𝗗𝗮𝘁𝗲 & 𝗧𝗶𝗺𝗲: 10:50-11:20 AM PST, Tuesday, March 11, 2025 • 𝗧𝗿𝗮𝗰𝗸: AI in Precision Medicine • 𝗦𝗲𝘀𝘀𝗶𝗼𝗻: Clinical Implementation of AI in Precision Medicine Chronic diseases affect billions and account for over 80% of healthcare spending, yet effective diagnosis and treatment options remain limited due to their complex biology. Steve's presentation will explore how an AI-driven precision medicine approach can enhance our understanding of the mechanisms causing chronic diseases. He will demonstrate how these insights are being used to: • Predict lifetime disease risk in patients • Diagnose major diseases earlier and with greater accuracy • Identify effective treatments targeting the biological drivers of disease • Prevent the onset and progression of diseases These advancements aim to improve health outcomes and reduce healthcare costs. We invite attendees to join Steve's session to learn more about how AI and precision medicine are transforming the landscape of chronic disease management. #PrecisionMedicine #ChronicDisease #PrecisionMedTriCon2025

At PrecisionLife we live and deliver gender equality at the forefront of #AIXBio expanding our understanding of disease biology and applying our predictive insights in healthcare and biopharma innovation. We recognize that World Economic Forum reported that closing the gap in women’s health is a $1T global economic opportunity. Our relentless focus to expand the understanding of disease mechanisms in chronic diseases includes diseases of the female reproductive organs like #endometriosis, #adenomyosis, #PCOS, Uterine fibroids and post partum depression. We also study diseases that disproportionally effect women including #lupus, #Sjӧgren’s, rheumatoid arthritis, #IBD, #longCOVID, #MECFS, #fibromyalgia, major depressive disorder, #MS and #migraine. In one of the world’s best AI, data science and bioinformatics teams 45% are female. The company has a woman founder, a woman board member and women in leadership roles in the executive, commercial and technical teams. Our position at the forefront of the field has been recognized by #EuEIC which recently awarded us an EIC accelerator grant award to develop #mechanostic test and repurposed treatments in endometriosis. In 2024, Johnson & Johnson shortlisted us as a finalist in their “Pitching AI for Pharmaceutical R&D QuickFire Challenge.” Our scientific peers cite our world first studies - we recently reproduced our genetic findings describing the mechanistic overlap between long COVID and MECFS. This is PrecisionLife. All of us, working with partners, to deliver better health, for everyone, every day. #IWD2025

Last week we shared a significant advancement in our understanding of long COVID and its implications for precision medicine. In collaboration with the Metrodora Foundation and Metrodora Institute, PrecisionLife has successfully reproduced key genetic associations for long COVID across populations with diverse ancestries. The new findings underscore the potential for developing precision diagnostics and targeted therapies for long COVID and related chronic conditions. By leveraging AI-led combinatorial analytics, we are uncovering the mechanisms underpinning complex diseases, paving the way for more effective, personalized treatments. This breakthrough exemplifies our commitment to driving precision medicine in complex chronic diseases, offering hope to billions affected worldwide. #PrecisionMedicine #LongCOVID #ChronicDiseases

🚀 We’re excited to announce that Steve Gardner, CEO & Co-founder of PrecisionLife, will be delivering a featured presentation at the 32nd Annual Precision Med Tri-Con in San Diego (March 11-13, 2025) before joining an expert panel discussion on AI and omics in precision medicine. 🎤 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻: 𝗜𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻, 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁, & 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗼𝗳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 📅 𝗪𝗵𝗲𝗻: Tuesday, March 11, 2025 | 10:50 AM PST 📍 𝗪𝗵𝗲𝗿𝗲: San Diego, CA Steve will showcase how our AI-driven combinatorial analytics platform is uncovering novel genetic insights into the mechanisms driving complex diseases to maximize the success of drug development, improve health outcomes and reduce health costs—helping to develop more precise diagnostics and therapies. 🔍 𝗣𝗮𝗻𝗲𝗹 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: 𝗢𝗺𝗶𝗰𝘀, 𝗗𝗮𝘁𝗮, 𝗮𝗻𝗱 𝗔𝗜 𝗶𝗻 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 📅 𝗪𝗵𝗲𝗻: March 12, 2025 | 12:00 PM PST 🗣 𝗣𝗮𝗻𝗲𝗹𝗶𝘀𝘁𝘀: • Steve Gardner, PhD – CEO & Co-founder, PrecisionLife • Kyle Kai-How Farh MD PhD, MD, PhD – VP & Distinguished Scientist, AI Lab, Illumina • Ryan Taft, PhD – SVP, Genomics R&D, Tempus AI • Eleanor Howe, PhD – Founder & CEO, Diamond Age Data Science 🎙 Moderator: Fay Lin, PhD, Senior Editor, Genetic Engineering & Biotechnology News 💡 This discussion will explore 𝗵𝗼𝘄 𝗔𝗜, 𝗺𝘂𝗹𝘁𝗶-𝗼𝗺𝗶𝗰𝘀 𝗱𝗮𝘁𝗮, 𝗮𝗻𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝗮𝗿𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲—uncovering new therapeutic insights and overcoming challenges in data accessibility, curation, and representation. 🔗 Join us in San Diego or follow for updates: https://lnkd.in/ewFbwnU8 #PrecisionMedicine #PrecisionMedTriCon2025

📰 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗟𝗶𝗳𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗡𝗲𝘄𝘀 𝘁𝗵𝗶𝘀 𝗪𝗲𝗲𝗸 Our efforts continue to uncover new insights into complex diseases, offering hope for better, more personalized diagnostics and treatments for patients with unmet medical needs. Check out a selection of the latest articles covering our research and partnerships: 1️⃣ 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗦𝘁𝘂𝗱𝘆 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝘀 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗧𝗮𝗿𝗴𝗲𝘁𝘀 𝗳𝗼𝗿 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 We’ve confirmed genetic factors behind long COVID for the first time to uncover potential therapeutic targets that could provide relief for millions worldwide. 🔗 https://lnkd.in/dU4SFEeB via Drug Discovery World 2️⃣ 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗖𝗹𝗼𝘀𝗲 𝗶𝗻 𝗼𝗻 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗼𝗳 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 Our research with Metrodora Foundation and Metrodora Institute sheds light on the genetic underpinnings of long COVID, bringing us closer to better diagnostics and targeted treatments. 🔗 https://lnkd.in/eqjQhS9S via Health Tech World 3️⃣ 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗟𝗶𝗳𝗲 𝗮𝗻𝗱 𝗠𝗲𝘁𝗿𝗼𝗱𝗼𝗿𝗮 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗞𝗲𝘆 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗳𝗼𝗿 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗔𝗰𝗿𝗼𝘀𝘀 𝗗𝗶𝘃𝗲𝗿𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 🔗 https://lnkd.in/gZQXuNfC via BioSpace 4️⃣ 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗟𝗶𝗳𝗲 𝗪𝗶𝗻𝘀 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 𝗳𝗼𝗿 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝘁𝗼 𝗗𝗲𝘁𝗲𝗰𝘁 𝗮𝗻𝗱 𝗧𝗿𝗲𝗮𝘁 𝗘𝗻𝗱𝗼𝗺𝗲𝘁𝗿𝗶𝗼𝘀𝗶𝘀 We’re thrilled to announce new funding from European Innovation Council and SMEs Executive Agency (EISMEA) to support our work in detecting and treating endometriosis, a condition affecting millions of women worldwide. 🔗 https://lnkd.in/dvX_ZkCb via Business Weekly newspaper 5️⃣ 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗟𝗶𝗳𝗲'𝘀 𝗧𝗿𝗮𝗻𝘀𝗰𝗲𝗻𝗱 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗪𝗶𝗻𝘀 𝗘𝗜𝗖 𝗔𝘄𝗮𝗿𝗱 𝘁𝗼 𝗗𝗲𝘁𝗲𝗰𝘁 𝗮𝗻𝗱 𝗧𝗿𝗲𝗮𝘁 𝗘𝗻𝗱𝗼𝗺𝗲𝘁𝗿𝗶𝗼𝘀𝗶𝘀 🔗 https://lnkd.in/dRvpstyH via BioIndustry Association (BIA) #PrecisionMedicine #LongCOVID #Endometriosis #Healthcare #Diagnostics